Yao-Yu Hsieh

查看斯高帕斯 (Scopus) 概要

電子郵件alecto39gmailcom

No. 250 Wu-Xing Street, Taipei 11031

h-index

每年研究成果

學歷

1997-2004 國立陽明大學醫學系醫學士

經歷

2022.08- 臺北醫學大學醫學系內科學科血液腫瘤科主任
2020.09- 衛生福利部雙和醫院內科部血液腫瘤科主任
2019.08- 臺北醫學大學醫學系內科學科助理教授
2013.02-2019.07 臺北醫學大學醫學系內科學科講師
2012- 衛生福利部雙和醫院化療安全小組召集人
2012- 衛生福利部雙和醫院血液腫瘤科病房主任
2011-2013 臺北醫學大學醫學系兼任講師
2011.09-2012.07 國立陽明大學醫學系兼任講師
2010- 臺北醫學大學署立雙和醫院血液腫瘤科主治醫師
2010 台北榮民總醫院血液腫瘤科主治醫師
2007-2010 台北榮民總醫院血液腫瘤科總醫師
2004-2007 台北榮民總醫院內科住院醫師
2002 國際醫學生大會籌備會委員
2002 中華民國醫學生聯合會國際交換學生至挪威Tromsoe大學附設醫院

獎項

2009 第14屆亞太骨髓移植學會傑出壁報論文獎

研究興趣

臨床試驗
腸胃道癌症臨床資料研究
腸胃道癌症藥物抗藥性探討

指紋

查看啟用 Yao-Yu Hsieh 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

1 類似的個人檔案

2 使用中
3 已完成

針對BTK/BCL2L11 axis的雙重標的對順鉑頑固型耐藥食道癌細胞的意義
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究-靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果 (2/3)
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
布鲁頓酪氨酸激酶(Bruton's tyrosine kinase , BTK)對頑固型耐藥食道癌細胞鐵死亡敏感性之機制研究
Hsieh, Y.-Y. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(1/3)
Hsieh, Y.-Y. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
透過老藥新用發現一個M5毒蕈鹼乙酰膽鹼受體之正向異位性調節劑可作為微管標靶藥物，及其應用於治療胰臟管腺癌
Hsieh, Y.-Y. (PI)
1/1/19 → 6/1/20
研究計畫: A - 政府部門 › b - 國家科學及技術委員會

39 文章
2 評論/辯論
1 快報
1 回顧型文獻

Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance
Hsieh, Y. Y., Du, J. L. & Yang, P. M., 2月 2024, 於: Molecular Oncology. 18, 2, p. 386-414 29 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
3 引文斯高帕斯（Scopus）
Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan
Huang, Y. C., Hsiao, F. Y., Guan, S. T., Yao, M., Liu, C. J., Chen, T. T., Lin, T. L., Liu, Y. C., Chen, T. Y., Hong, Y. C., Ma, M. C., Tan, T. D., Wang, C. C., Wu, Y. Y., Liao, P. W., Wu, Y. F., Chen, Y. Y., Yu, Y. B., Hsieh, Y. Y. & Lee, M. Y. 及其他3, Liu, J. H., Lin, S. W. & Ko, B. S., 2024, (接受/付印) 於: Journal of Microbiology, Immunology and Infection. 57, 3, p. 365-374 10 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
2 引文斯高帕斯（Scopus）
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
Wang, S. H., Hsieh, Y. Y., Ong, K. H., Lai, H. Y., Tsai, H. H., Sun, D. P., Huang, S. K. H., Tian, Y. F., Wu, H. C., Chan, T. C., Joseph, K. & Chang, I. W., 2024, (接受/付印) 於: Asian Journal of Surgery. 48, 1, p. 250-260 11 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection
Lee, C. H., Hsu, K. W., Hsieh, Y. Y., Li, W. T., Long, Y., Lin, C. Y. & Chen, S. H., 4月 2024, 於: Cells. 13, 7, 616.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East
Jain, S., Dawood, S., Lavingia, V., Aderka, D., Tahover, E., Hsieh, Y. Y., Temper, M., Goldman, A., Akasheh, M. A. I., Olsen, S., Hsing, S. S., Joshi, N. & Jen, H. Y., 2024, 於: Frontiers in Oncology. 14, 1426941.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
Liu, T.-P. (Contributor), Yang, P.-M. (Creator), Hsieh, Y.-Y. (Creator) & Chou, C.-J. (Contributor), The Royal Society, 2018
DOI: 10.6084/m9.figshare.7346312.v2, https://doi.org/10.6084%2Fm9.figshare.7346312.v2
資料集: Dataset
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v2, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/2
資料集: Dataset
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v1, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/1
資料集: Dataset
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.7375601.v1, https://rs.figshare.com/articles/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7375601/1
資料集: Dataset
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, 1月 1 2018
DOI: 10.6084/m9.figshare.7346312.v1, https://rs.figshare.com/articles/journal_contribution/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7346312/1
資料集: Dataset

謝燿宇

個人檔案

學歷

經歷

獎項

研究興趣

指紋

過去五年中的合作和熱門研究領域

深入探索詳細資料

針對BTK/BCL2L11 axis的雙重標的對順鉑頑固型耐藥食道癌細胞的意義

靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究-靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果 (2/3)

布鲁頓酪氨酸激酶(Bruton's tyrosine kinase , BTK)對頑固型耐藥食道癌細胞鐵死亡敏感性之機制研究

靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(1/3)

透過老藥新用發現一個M5毒蕈鹼乙酰膽鹼受體之正向異位性調節劑可作為微管標靶藥物，及其應用於治療胰臟管腺癌

Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance

Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan

The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma

Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection

Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East

Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.

Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"

Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"

Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining

Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining

謝 燿宇

個人檔案

學歷

經歷

獎項

研究興趣

指紋

過去五年中的合作和熱門研究領域

專案

研究成果

資料集

謝燿宇